|
IL86278A
(en)
|
1988-05-04 |
2003-06-24 |
Yeda Res & Dev |
Endowing cells with antibody specificity using chimeric t cell receptor
|
|
US6790614B1
(en)
|
1999-11-19 |
2004-09-14 |
Novartis Ag |
Selectable cell surface marker genes
|
|
TR201904484T4
(tr)
|
2009-11-03 |
2019-05-21 |
Hope City |
Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt).
|
|
ES2657970T3
(es)
|
2010-12-01 |
2018-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticuerpos contra ROR1 de conejo/ser humano quiméricos
|
|
CA2861491C
(en)
|
2012-02-13 |
2020-08-25 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
US10611837B2
(en)
|
2014-04-10 |
2020-04-07 |
Seattle Children's Hospital |
Transgene genetic tags and methods of use
|
|
DE112014006603A5
(de)
*
|
2014-04-20 |
2017-01-19 |
new/era/mabs GmbH |
Biomoleküle freisetzende Zelle und deren Selektion mittels eines Oberflächenproteins sowie für dieses codierende Nukleinsäure, deren Expressionsvektor und dessen Empfängerzelle
|
|
PL3134432T3
(pl)
*
|
2014-04-25 |
2020-10-19 |
Bluebird Bio, Inc. |
Promotor mnd chimeryczne receptory antygenowe
|
|
BR112017013981A2
(pt)
|
2015-01-26 |
2018-01-02 |
Cellectis |
receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer
|
|
EP3347026A4
(en)
|
2015-09-09 |
2019-05-08 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
GENEMANIPULATION OF MACROPHAGES FOR IMMUNOTHERAPY
|
|
MX2018004721A
(es)
|
2015-10-23 |
2018-07-06 |
Eureka Therapeutics Inc |
Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
|
|
CN106967684A
(zh)
|
2016-01-13 |
2017-07-21 |
北京马力喏生物科技有限公司 |
共表达抗EGFRvIII嵌合抗原受体和无功能EGFR受体的转基因淋巴细胞及其用途
|
|
CN106967681B
(zh)
|
2016-01-13 |
2020-06-05 |
北京马力喏生物科技有限公司 |
治疗脑胶质母细胞瘤的治疗组合物
|
|
CN107586342A
(zh)
|
2016-07-08 |
2018-01-16 |
生命序有限公司 |
重组免疫检查点受体及其应用
|
|
CN107586341A
(zh)
|
2016-07-08 |
2018-01-16 |
生命序有限公司 |
重组免疫检查点受体及免疫检查点抑制分子的共表达及应用
|
|
CN108342360A
(zh)
|
2017-01-25 |
2018-07-31 |
北京马力喏生物科技有限公司 |
共表达抗msln嵌合抗原受体和无功能egfr的转基因淋巴细胞及其用途
|
|
CN108342361B
(zh)
|
2017-01-25 |
2020-12-22 |
北京马力喏生物科技有限公司 |
治疗间质素阳性肿瘤的治疗组合物
|
|
JP7538601B2
(ja)
|
2017-04-26 |
2024-08-22 |
ユーリカ セラピューティックス， インコーポレイテッド |
キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用
|
|
CN110573177A
(zh)
|
2017-04-28 |
2019-12-13 |
尤利乌斯·马克西米利安维尔茨堡大学 |
具有人源化靶向结构域的ror1特异性嵌合抗原受体(car)
|
|
EP4269560A3
(en)
|
2017-10-03 |
2024-01-17 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
|
WO2019072824A1
(en)
|
2017-10-09 |
2019-04-18 |
Cellectis |
IMPROVED ANTI-CD123 CAR IN UNIVERSAL MODIFIED IMMUNE T LYMPHOCYTES
|
|
EP3723774A4
(en)
|
2017-12-15 |
2021-09-08 |
The Board of Trustees of the Leland Stanford Junior University |
COMPOSITIONS AND METHODS OF INHIBITION OF T-CELL EXHAUSTATION
|
|
US20230158070A1
(en)
|
2018-01-30 |
2023-05-25 |
Cellectis |
Combination comprising allogeneic immune cells deficient for an antigen present on both t-cells and pathological cells and therapeutic antibody against said antigen
|
|
US10663465B2
(en)
*
|
2018-03-05 |
2020-05-26 |
The Hong Kong University Of Science And Technology |
Disruption of EGFR-SAR1 interaction for cancer treatment
|
|
CN110526983B
(zh)
|
2018-05-24 |
2022-02-11 |
北京马力喏生物科技有限公司 |
改良型抗cd19 car-t细胞
|
|
CA3105816A1
(en)
|
2018-07-10 |
2020-01-16 |
Precigen, Inc. |
Ror-1 specific chimeric antigen receptors and uses thereof
|
|
US20210322473A1
(en)
|
2018-07-18 |
2021-10-21 |
The General Hospital Corporation |
Modified t cells and methods of their use
|
|
KR20210074274A
(ko)
|
2018-08-06 |
2021-06-21 |
시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 |
합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물
|
|
EP3836944A4
(en)
|
2018-08-16 |
2022-05-11 |
Memorial Sloan Kettering Cancer Center |
LEUCINE ZIPPER BASED COMPOSITIONS AND METHODS OF USE
|
|
CN112996819B
(zh)
|
2018-08-16 |
2025-11-04 |
纪念斯隆-凯特琳癌症中心 |
细胞分选系统及使用方法
|
|
CN113166226B
(zh)
|
2018-09-28 |
2025-06-27 |
纪念斯隆-凯特琳癌症中心 |
表达显性负性fas的免疫应答细胞及其用途
|
|
EP3860642A1
(en)
*
|
2018-10-05 |
2021-08-11 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
CN111088231A
(zh)
|
2018-10-24 |
2020-05-01 |
艾生命序公司 |
Pd-l1抗体分泌的抗间皮素car-t细胞肿瘤免疫治疗
|
|
AU2019372673A1
(en)
|
2018-11-01 |
2021-05-27 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for T cell engineering
|
|
WO2020187016A1
(zh)
|
2019-03-15 |
2020-09-24 |
阿思科力(苏州)生物科技有限公司 |
携带自杀基因的robo1 car-nk细胞及其制备方法和应用
|
|
CA3158133A1
(en)
|
2020-04-28 |
2021-11-04 |
Lyell Immunopharma, Inc. |
Methods for culturing cells
|
|
BR112022022953A2
(pt)
|
2020-05-12 |
2023-03-21 |
Lyell Immunopharma Inc |
Espaçadores de receptores de antígenos quiméricos
|
|
EP4298230A1
(en)
|
2021-02-25 |
2024-01-03 |
Lyell Immunopharma, Inc. |
Codon-optimized nucleotide sequences encoding an ap-1 transcription factor
|
|
US12144827B2
(en)
|
2021-02-25 |
2024-11-19 |
Lyell Immunopharma, Inc. |
ROR1 targeting chimeric antigen receptor
|
|
EP4298208A1
(en)
|
2021-02-25 |
2024-01-03 |
Lyell Immunopharma, Inc. |
Methods for culturing cells
|